Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Osteoporosis 1Multiple Myeloma 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Calcium 6Letrozole 4Cholecalciferol 4Calcium Carbonate 4Alendronate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Estradiol 2Denosumab 2Calcium Gluconate 2Aromatase Inhibitors 2Absorptiometry, Photon 2xian ling gu bao 1romosozumab 1X-Rays 1Technetium 1Raloxifene Hydrochloride 1Progesterone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Lysine Acetyltransferase 5 1Ibandronic Acid 1Hormone Replacement Therapy 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Osteoporosis × romosozumab × Clear all
NCT05775094 2025-12-19

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
10 enrolled
Plasma cell

Multiple Myeloma, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡